I think that this is the new peptide test that Prof. Scheibenbogen has developed with JPT Technologies?
https://shop.jpt.com/1-PepMix-trade...ections/1314-PepMix-trade-Collection-EBV.html
It fits with their 2014 paper on the EBV immune response in CFS patients, so maybe this might be a new diagnostic test for a subset (EBV-triggered) of CFS patients?
https://shop.jpt.com/1-PepMix-trade...ections/1314-PepMix-trade-Collection-EBV.html
It fits with their 2014 paper on the EBV immune response in CFS patients, so maybe this might be a new diagnostic test for a subset (EBV-triggered) of CFS patients?